Lantheus logo

Lantheus Share Price Today

(NASDAQ: LNTH)

Lantheus share price is $100.48 & ₹8,738.65 as on 6 Mar 2025, 2.30 'hrs' IST

$100.48

2.31

(2.35%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Lantheus share price in Dollar and Rupees. Guide to invest in Lantheus stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lantheus, along with analyst recommendations, forecasts, and comprehensive financials.

Lantheus share price movements

  • Today's Low: $97.38
    Today's High: $101.16

    Day's Volatility :3.74%

  • 52 Weeks Low: $56.44
    52 Weeks High: $126.89

    52 Weeks Volatility :55.52%

Lantheus (LNTH) Returns

PeriodLantheus HoldingsSector (Health Care)Index (Russel 2000)
3 Months
9.88%
2.1%
0.0%
6 Months
-6.81%
-4.1%
0.0%
1 Year
58.42%
2.2%
0.0%
3 Years
89.63%
11.8%
-11.6%

Lantheus (LNTH) Key Statistics

in dollars & INR

Previous Close
$98.17
Open
$98.0
Today's High
$101.16
Today's Low
$97.38
Market Capitalization
$6.5B
Today's Volume
$312.7K
52 Week High
$126.8899
52 Week Low
$56.44
Revenue TTM
$1.5B
EBITDA
$510.5M
Earnings Per Share (EPS)
$4.36
PE Ratio
21.76
Profit Margin
20.37%
Quarterly Earnings Growth YOY
-0.05%
Return On Equity TTM
32.82%

How to invest in Lantheus Stock (LNTH) from India?

It is very easy for Indian residents to invest directly in Lantheus from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lantheus stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lantheus or LNTH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lantheus or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lantheus shares which would translate to 0.009 fractional shares of Lantheus as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lantheus, in just a few clicks!

Returns in Lantheus (LNTH) for Indian investors in Rupees

The Lantheus stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lantheus investment value today

Current value as on today

₹1,67,106

Returns

₹67,106

(+67.11%)

Returns from Lantheus Stock

₹62,143 (+62.14%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Lantheus (LNTH)

7%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Lantheus Stock from India on INDmoney has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lantheus

  • BlackRock Inc

    12.58%

  • Vanguard Group Inc

    10.58%

  • HHG PLC

    9.05%

  • Farallon Capital Management, L.L.C.

    7.76%

  • State Street Corp

    3.86%

  • FMR Inc

    3.66%

Analyst Recommendation on Lantheus

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Lantheus(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
15
15
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Lantheus Stock (LNTH)

What analysts predicted

Upside of 33.28%

Target:

$133.92

Current:

$100.48

Insights on Lantheus Stock (Ticker Symbol: LNTH)

  • Price Movement

    In the last 7 days, LNTH stock has moved up by 5.3%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 378.73M → 391.11M (in $), with an average increase of 3.2% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 131.09M → -11.79M (in $), with an average decrease of 109.0% per quarter
  • LNTH vs ITCI (1 yr)

    In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 44.7%
  • LNTH vs ITCI (3 yr)

    In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 50.5%
  • Price to Sales

    ForLNTH every $1 of sales, investors are willing to pay $4.4, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

Lantheus Technicals Summary

Sell

Neutral

Buy

Lantheus is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Lantheus (LNTH) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lantheus Holdings logo
9.64%
-6.81%
58.42%
89.63%
299.23%
Intra-cellular Therapies, Inc. logo
3.42%
81.22%
98.76%
146.55%
588.92%
Haleon Plc Spon Ads logo
12.55%
3.39%
28.09%
43.99%
43.99%
Zoetis Inc. logo
-1.19%
-8.94%
-7.43%
-9.67%
30.97%
Neurocrine Biosciences Inc. logo
-24.64%
-6.68%
-14.47%
28.61%
27.88%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lantheus Holdings logo
21.76
21.76
0.61
6.98
0.33
0.15
NA
15.9
Intra-cellular Therapies, Inc. logo
NA
NA
0.0
0.13
-0.09
-0.07
NA
10.81
Haleon Plc Spon Ads logo
26.68
26.68
1.5
0.36
0.09
0.04
0.02
1.8
Zoetis Inc. logo
31.17
31.17
3.01
6.07
0.51
0.15
0.01
10.64
Neurocrine Biosciences Inc. logo
34.8
34.8
0.27
6.47
0.14
0.1
NA
26.05
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lantheus Holdings logo
Buy
$6.5B
299.23%
21.76
20.37%
Intra-cellular Therapies, Inc. logo
Buy
$14.0B
588.92%
NA
-10.97%
Haleon Plc Spon Ads logo
Buy
$48.2B
43.99%
26.68
12.84%
Zoetis Inc. logo
Buy
$76.1B
30.97%
31.17
26.86%
Neurocrine Biosciences Inc. logo
Buy
$11.3B
27.88%
34.8
14.49%

About Lantheus

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. It also provides Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; PYLARIFY AI, an medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer; and flurpiridaz used to assess blood flow to the heart. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy to patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent for Tau tangles in Alzheimer's disease; LNTH-2401, a novel radiodiagnostic targeting the gastrin-releasing peptide receptor; LNTH-2402; LNTH-2403; LNTH-2404; and LNTH-1363S, an fibroblast activation protein, alpha, copper-64 labeled PET imaging agent. It has collaboration agreements with GE Healthcare; POINT; Regeneron; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.
Organization
Lantheus
Employees
808
CEO
Mr. Brian A. Markison
Industry
Health Technology

Management People of Lantheus

NameTitle
Mr. Brian A. Markison
CEO & Director
Mr. Paul M. Blanchfield
President
Mr. Robert J. Marshall Jr., CFA
CFO & Treasurer
Dr. Jean-Claude Provost M.D.
Chief Science Officer
Mr. Daniel M. Niedzwiecki
Chief Administrative Officer, General Counsel & Corporate Secretary
Ms. Kimberly Brown
Chief Accounting Officer
Ms. Dorothy Barr
Senior Vice President of Manufacturing & Technical Operations
Ms. Lee Anne Howe
Chief Information Officer
Mr. Mark Richard Kinarney
Senior Director of Investor Relations
Ms. Linda S. Lennox
VP of Corporate Communications & Chief of Staff

Important FAQs about investing in LNTH Stock from India :

What is Lantheus share price today?

Lantheus share price today stands at $100.48, Open: $98.00 ; Previous Close: $98.17 ; High: $101.16 ; Low: $97.38 ; 52 Week High: $126.89 ; 52 Week Low: $56.44.

The stock opens at $98.00, after a previous close of $98.17. The stock reached a daily high of $101.16 and a low of $97.38, with a 52-week high of $126.89 and a 52-week low of $56.44.

Can Indians buy Lantheus shares?

Yes, Indians can invest in the Lantheus (LNTH) from India.

With INDmoney, you can buy Lantheus at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lantheus at zero transaction cost.

How can I buy Lantheus shares from India?

It is very easy to buy Lantheus from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lantheus (LNTH) be purchased?

Yes, you can buy fractional shares of Lantheus with INDmoney app.

What are the documents required to start investing in Lantheus stocks?

To start investing in Lantheus, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lantheus Stock (LNTH)?

Today’s highest price of Lantheus (LNTH) is $101.16.

Today’s lowest price of Lantheus (LNTH) is $97.38.

What is today's market capitalisation of Lantheus?

Today's market capitalisation of Lantheus LNTH is 6.5B

What is the 52 Week High and Low Range of Lantheus Stock (LNTH)?

  • 52 Week High

    $126.89

  • 52 Week Low

    $56.44

What are the historical returns of Lantheus (LNTH)?

  • 1 Month Returns

    9.64%

  • 3 Months Returns

    -6.81%

  • 1 Year Returns

    58.42%

  • 5 Years Returns

    299.23%

Who is the Chief Executive Officer (CEO) of Lantheus ?

Mr. Brian A. Markison is the current Chief Executive Officer (CEO) of Lantheus.